My ePortfolio Register   

SIOG 2014 /
Implications of targeted cancer therapies for elderly patients

23rd - 25th Oct 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.11.14
Views: 1920

Prof Vesa Kataja - Kuopio University Hospital, Kuopio, Finland

At SIOG 2014, Prof Kataja speaks to ecancertv about the challenges of using new cancer therapeutics on the elderly population.

The latest therapeutics, such as targeted therapies, are rarely trialled on the elderly - what implications does this have for treatment?

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence